North America

Narcolepsy Gets Treated at the Cause

More spice did not improve post-meal metabolism. A four-week trial complicates the heart-health story

Lymphoma Is Testing How Far Chemo-Free Care Can Go

Cancer Survivorship Standards Are Still Mostly Paper

MS Prevention Is Still Too Passive

Four in five young adults in an urban U.S. cohort had CKM risk factors. Cardiovascular prevention is arriving too late

Breast Cancer Immunotherapy Has a New Problem: Who Gets the Second Checkpoint?

Avexitide Phase 3 trial cuts post-bariatric hypoglycemia events by 55%

Alzheimer’s Diagnosis Gets Another Gate
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
